Cibus, Inc.
CBUSHealthcare|Biotechnology|US
$1.18
+0.04 (+3.51%)
Cash / Share
$0.27
Financials
Financial Snapshot
Market Cap
$90.2M
Enterprise Value
$102.5M
Revenue (TTM)
$4.3M
Net Income (TTM)
-$98.2M
Cash & Investments
$20.4M
Net Cash
-$12.3M
Free Cash Flow (TTM)
-$46.3M
Operating CF (TTM)
-$46.1M
Debt/Equity
2.21
Cash Runway & Burn Rate
Cash on Hand
$20.4M
Quarterly Burn
$11.5M
Monthly Burn
$3.8M
Est. Runway
~1.8 quarters
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $5.0M | $56.7M | $93.8M | $58.6M | $29.0M | $13.8M | $3.4M | $32.7M | $14.4M | $9.9M | $20.4M | |
| Operating Cash Flow | -$9.2M | -$12.8M | -$20.3M | -$32.0M | -$43.7M | -$18.8M | -$19.4M | -$46.2M | -$58.0M | -$50.6M | -$46.1M | |
| Free Cash Flow | -$19.7M | -$13.6M | -$22.1M | -$34.9M | -$45.5M | -$19.3M | -$20.9M | -$50.5M | -$58.9M | -$51.2M | -$46.3M | |
| Capital Expenditure | -$10.4M | -$779.0K | -$1.8M | -$3.0M | -$1.8M | -$497.0K | -$1.5M | -$4.3M | -$808.0K | -$578.0K | -$267.0K | |
| Financing Cash Flow | $0.00 | $65.2M | $60.7M | -$330.0K | $15.4M | $3.7M | $10.0M | $20.3M | $40.6M | $46.6M | $30.3M |
R&D Spending
R&D (TTM)
$37.4M
R&D Intensity
860.2%
R&D Growth vs Prior
-15.4%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $399.0K | $508.0K | $236.0K | $7.3M | $23.9M | $26.0M | $157.0K | $1.8M | $4.3M | $3.6M | $4.3M | |
| R&D Expense | $5.6M | $11.6M | $9.8M | $12.2M | $11.1M | $11.3M | $11.6M | $42.4M | $50.4M | $44.2M | $37.4M | |
| R&D % of Revenue | 1413.0% | 2274.8% | 4172.0% | 167.4% | 46.5% | 43.6% | 7358.6% | 2331.7% | 1183.2% | 1214.6% | 860.2% | |
| SG&A | $6.7M | $14.7M | $18.5M | $24.1M | $20.8M | $15.4M | $9.4M | $28.9M | $30.8M | $26.9M | $19.7M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $399.0K | $508.0K | $236.0K | $7.3M | $23.9M | $26.0M | $157.0K | $1.8M | $4.3M | $3.6M | $4.3M | |
| Cost of Revenue | $200.0K | $551.0K | $1.1M | $9.3M | $35.1M | $28.6M | $1.5M | $395.0K | $6.9M | $5.9M | $2.4M | |
| Gross Profit | $199.0K | -$43.0K | -$845.0K | -$2.0M | -$11.3M | -$2.6M | -$1.4M | $1.4M | -$2.6M | -$2.3M | $2.0M | |
| R&D | $5.6M | $11.6M | $9.8M | $12.2M | $11.1M | $11.3M | $11.6M | $42.4M | $50.4M | $44.2M | $37.4M | |
| SG&A | $6.7M | $14.7M | $18.5M | $24.1M | $20.8M | $15.4M | $9.4M | $28.9M | $30.8M | $26.9M | $19.7M | |
| Operating Income | -$12.1M | -$25.8M | -$28.1M | -$39.7M | -$43.8M | -$29.3M | -$22.4M | -$318.9M | -$77.0M | -$67.5M | -$53.9M | |
| Interest Expense | $5.0K | $1.0K | $1.3M | $1.5M | $1.4M | $1.4M | $87.0K | $18.9M | $34.2M | $35.5M | $18.8M | |
| Pretax Income | -$12.1M | -$26.0M | -$27.9M | -$39.6M | -$44.8M | -$29.2M | -$16.9M | -$337.6M | -$282.7M | -$132.2M | -$99.6M | |
| Net Income | -$12.1M | -$26.0M | -$27.9M | -$39.6M | -$44.8M | -$29.2M | -$16.9M | -$267.6M | -$251.4M | -$127.1M | -$98.2M | |
| EPS (Diluted) | -21.86 | -46.86 | -45.46 | -60.37 | -66.16 | -38.96 | -18.36 | -25.95 | -10.83 | -2.78 | -1.65 | |
| EBITDA | -$11.7M | -$25.2M | -$25.6M | -$36.5M | -$41.5M | -$25.4M | -$15.2M | -$314.6M | -$241.6M | -$90.8M | -$57.5M | |
| Shares Out. (M) | 0.55 | 0.55 | 0.61 | 0.66 | 0.68 | 0.75 | 0.92 | 10.31 | 23.22 | 45.76 | 76.76 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.0M | $56.7M | $93.8M | $58.6M | $17.3M | $13.8M | $3.4M | $32.7M | $14.4M | $9.9M | $20.4M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $11.7M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $5.5M | $57.5M | $95.5M | $63.5M | $39.6M | $15.2M | $4.1M | $35.2M | $16.9M | $12.1M | $23.5M | |
| Total Assets | $16.6M | $72.2M | $118.8M | $88.1M | $63.3M | $37.2M | $22.4M | $544.4M | $350.1M | $305.0M | $313.4M | |
| Total Current Liabilities | $2.9M | $4.3M | $7.0M | $7.2M | $6.9M | $4.9M | $1.7M | $21.3M | $19.9M | $16.9M | $14.4M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $1.5M | $0.00 | $0.00 | $536.0K | $226.0K | $235.0M | $53.0K | |
| Total Liabilities | $3.5M | $14.7M | $25.4M | $25.6M | $26.5M | $23.1M | $15.2M | $206.1M | $252.2M | $283.2M | $298.6M | |
| Stockholders' Equity | $13.1M | $57.5M | $93.4M | $62.5M | $36.9M | $14.1M | $7.2M | $293.5M | $92.2M | $21.8M | $14.8M | |
| Retained Earnings | -$28.6M | -$54.5M | -$82.4M | -$122.1M | -$166.9M | -$196.1M | -$212.2M | -$479.8M | -$731.2M | -$858.3M | -$901.6M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.2M | -$12.8M | -$20.3M | -$32.0M | -$43.7M | -$18.8M | -$19.4M | -$46.2M | -$58.0M | -$50.6M | -$46.1M | |
| Capital Expenditure | -$10.4M | -$779.0K | -$1.8M | -$3.0M | -$1.8M | -$497.0K | -$1.5M | -$4.3M | -$808.0K | -$578.0K | -$267.0K | |
| Free Cash Flow | -$19.7M | -$13.6M | -$22.1M | -$34.9M | -$45.5M | -$19.3M | -$20.9M | -$50.5M | -$58.9M | -$51.2M | -$46.3M | |
| Investing Cash Flow | -$10.4M | -$779.0K | -$1.8M | -$3.0M | -$13.5M | $11.2M | -$1.5M | $55.1M | -$808.0K | -$578.0K | -$224.0K | |
| Financing Cash Flow | $0.00 | $65.2M | $60.7M | -$330.0K | $15.4M | $3.7M | $10.0M | $20.3M | $40.6M | $46.6M | $30.3M | |
| Issuance of Stock | $0.00 | $61.3M | $57.7M | $344.0K | $15.0M | $4.6M | $11.5M | $18.8M | $43.9M | $47.9M | $32.1M | |
| Repurchase of Stock | $0.00 | $0.00 | -$230.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $7.0M | $1.2M | $139.0K | $1.2M | -$364.0K | -$376.0K | -$194.0K | -$879.0K | -$1.1M | -$1.2M | |
| Stock Based Comp. | $948.0K | $12.1M | $4.4M | $9.2M | $5.0M | $2.1M | $4.0M | $16.1M | $10.8M | $8.2M | $6.8M | |
| Net Change in Cash | -$19.7M | $51.6M | $38.6M | -$35.2M | -$41.7M | -$3.9M | -$10.9M | $29.2M | -$18.3M | -$4.5M | -$16.0M |
Dilution Tracker
Shares outstanding grew 6652.4% over 5 years — significant dilution
Shares Outstanding
76M
5-Year Share Growth
+6652.4%
Stock Issuance (TTM)
$32.1M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.55 | 0.55 | 0.61 | 0.66 | 0.68 | 0.75 | 0.92 | 10.31 | 23.22 | 45.76 | 76.76 | |
| Change vs Prior % | — | 0.2% | 10.7% | 6.9% | 3.3% | 10.6% | 22.7% | 1021.2% | 125.1% | 97.0% | 67.7% | |
| Stock Issuance | $0.00 | $61.3M | $57.7M | $344.0K | $15.0M | $4.6M | $11.5M | $18.8M | $43.9M | $47.9M | $32.1M | |
| Stock Repurchase | $0.00 | $0.00 | -$230.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $948.0K | $12.1M | $4.4M | $9.2M | $5.0M | $2.1M | $4.0M | $16.1M | $10.8M | $8.2M | $6.8M |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 49.9% | -8.5% | -358.1% | -27.2% | -47.3% | -9.9% | -877.1% | 78.3% | -60.9% | -62.8% | 45.7% | |
| Operating Margin % | -3034.8% | -5076.6% | -11913.1% | -543.8% | -183.8% | -112.9% | -14248.4% | -17550.0% | -1805.8% | -1853.9% | -1240.9% | |
| Net Margin % | -3029.1% | -5114.2% | -11820.8% | -542.9% | -188.0% | -112.4% | -10758.6% | -14729.1% | -5898.4% | -3492.3% | -2258.9% | |
| EBITDA Margin % | -2941.4% | -4954.3% | -10830.1% | -500.5% | -174.1% | -97.9% | -9687.9% | -17313.4% | -5669.5% | -2494.3% | -1323.3% | |
| FCF Margin % | -4927.6% | -2670.1% | -9364.0% | -478.6% | -190.6% | -74.3% | -13301.9% | -2781.0% | -1380.8% | -1406.1% | -1065.6% | |
| ROE % | -92.1% | -45.2% | -29.9% | -63.4% | -121.6% | -206.6% | -233.5% | -91.2% | -272.8% | -582.2% | -320.6% | |
| ROA % | -72.7% | -36.0% | -23.5% | -45.0% | -70.8% | -78.5% | -75.3% | -49.2% | -71.8% | -41.7% | -31.3% | |
| ROIC % | -88.0% | -38.0% | -25.1% | -48.8% | -77.2% | -89.7% | -105.4% | -60.2% | -23.0% | -23.2% | -17.8% | |
| R&D / Revenue % | 1413.0% | 2274.8% | 4172.0% | 167.4% | 46.5% | 43.6% | 7358.6% | 2331.7% | 1183.2% | 1214.6% | 860.2% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -68.6% | 27.3% | -53.5% | 2991.5% | 226.9% | 9.0% | -99.4% | 1057.3% | 134.6% | -14.6% | |
| Gross Profit | -61.8% | -121.6% | -1865.1% | -134.8% | -468.3% | 77.2% | 46.4% | 203.3% | -282.6% | 12.1% | |
| Operating Income | -108.3% | -113.0% | -9.0% | -41.1% | -10.5% | 33.1% | 23.7% | -1325.5% | 75.9% | 12.3% | |
| Net Income | -105.2% | -115.0% | -7.4% | -42.0% | -13.2% | 34.9% | 42.2% | -1484.4% | 6.1% | 49.4% | |
| EPS (Diluted) | -105.3% | -114.4% | 3.0% | -32.8% | -9.6% | 41.1% | 52.9% | -41.3% | 58.3% | 74.3% | |
| Operating Cash Flow | -38.1% | -38.4% | -58.4% | -57.8% | -36.7% | 56.9% | -2.9% | -138.6% | -25.6% | 12.8% | |
| Free Cash Flow | -167.3% | 31.0% | -62.9% | -58.0% | -30.2% | 57.5% | -8.2% | -142.0% | -16.5% | 13.1% | |
| R&D Expense | 103.8% | 105.0% | -14.8% | 24.0% | -9.3% | 2.3% | 1.9% | 266.7% | 19.0% | -12.4% | |
| SG&A Expense | 86.9% | 121.0% | 25.5% | 30.4% | -13.9% | -26.0% | -38.6% | 206.3% | 6.5% | -12.6% | |
| Total Assets | -36.1% | 334.1% | 64.6% | -25.8% | -28.1% | -41.3% | -39.7% | 2328.1% | -35.7% | -12.9% | |
| Book Value / Share | -45.9% | 337.0% | 46.8% | -37.4% | -42.9% | -65.4% | -58.3% | 317.1% | -87.2% | -88.7% | |
| Debt | 0.0% | 0.0% | 82.2% | 0.6% | 6.2% | -9.5% | -22.2% | 77.0% | 47.4% | 638.5% | |
| Diluted Shares | 0.0% | 0.2% | 10.7% | 6.9% | 3.3% | 10.6% | 22.7% | 1021.2% | 125.1% | 97.0% |
Valuation
P/E (TTM)At Loss
P/S20.75
10Y Low / Med / High3.07 / 43.36 / 1346.95
P/B6.12
10Y Low / Med / High0.69 / 3.68 / 23.71
EV/EBITDAAt Loss
EV/Revenue23.58
10Y Low / Med / High3.23 / 107.04 / 1110.49
P/FCFAt Loss
Intrinsic Value Models (per share)
Cash / Share
$0.27
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -25.73 | -23.51 | -11.39 | -5.81 | -3.19 | -2.73 | -0.40 | -0.76 | -0.26 | -0.63 | -0.72 | |
| P/S Ratio | 779.61 | 1202.06 | 1346.95 | 31.52 | 5.99 | 3.07 | 43.36 | 111.49 | 15.15 | 21.88 | 20.75 | |
| P/B Ratio | 23.71 | 10.62 | 3.40 | 3.68 | 3.88 | 5.65 | 0.94 | 0.69 | 0.70 | 3.65 | 6.12 | |
| EV/EBITDA | -26.08 | -22.41 | -9.49 | -5.20 | -3.50 | -3.30 | -1.14 | -0.62 | -0.36 | -3.72 | -1.78 | |
| EV/Revenue | 767.01 | 1110.49 | 1027.84 | 26.04 | 6.10 | 3.23 | 110.14 | 107.04 | 20.27 | 92.79 | 23.58 |
Analyst Estimates & Quality
Altman Z-Score
-4.46
Distress
Piotroski F-Score
3
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $5.2M | $12.4M | $47.5M |
| Net Income | -$56.8M | -$26.6M | -$14.7M |
| EPS | $-0.85 | $-0.64 | $-0.32 |
| # Analysts (EPS) | 2 | 2 | 3 |
Revenue Segments
By Product
| Segment | 2024 | 2025 |
|---|---|---|
| Reportable Segment | $4.3M | $3.6M |